115 results
DEFR14A
ARAV
Aravive Inc
22 Sep 23
Revised proxy
5:04pm
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting … , if Other Than the Registrant)
Payment of Filing Fee (check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee
8-K
EX-10.1
ygobfjudhy5ksbsdrj3
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
D
pz86644xt6bbaf pu
28 Oct 22
$41.56 mm in equity / options / securities to be acquired, sold $41.56 mm, 17 investors
4:11pm
8-K/A
EX-10.1
v9991950i82vh75lcsgw
28 Oct 22
Other Events
4:05pm
8-K
EX-10.1
ql8m1wl8sql61nmnu he
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.2
e0yazinjuk sp9apj7x
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
i5vcwf53
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
hq869
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.2
7hcq7dl1l h6
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm